شيوع آنتي بادي عليه ويروس هپاتيت C در بيماران همودياليزي مراجعه كننده به مركز همودياليز جهرم

Prevalence of Anti-HCV antibody in haemodialysis patients referring to haemodialysis unit of Jahrom

Introduction: Hepatitis C virus (HCV) is a major cause of chronic liver disease among chronic renal failure (CRF) patients undergoing maintenance hemodialysis. The present study aimed to investigate the prevalence of HCV infection in patients on haemodialysis of Jahrom. Materials and Methods: This cross-sectional study was caaried out on all haemodialysis patients of Jahrom in April - May 2006. All patients were screened for anti-HCV antibodies, using ELISA and confirmed by using R1BA methods. Results: We found that 3 patients (8.8%) were anti-HCV positive by ELISA and 2 (5.9%) patients were confirmed by using RIBA methods. Conclusion: Seroprevalence of HCV in the heamodialysis patients of Jahrom was 5.9% that is lower than seroprevalence of HCV in haemodialysis patients of other countries.